Increased PSA Screening Associated With Lower Risk of Advanced Prostate Cancer at Diagnosis, Mortality in Younger African American Patients June 6, 2021 Frequent prostate-specific antigen screenings may lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men.Conducting frequent prostate-specific antigen (PSA) screenings was found to lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men, according to study data to be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.Read the full article here. About Prostate Cancer Health Equity Prostate Cancer News Screening & PSA Test Testing & Diagnosis More for you
Frequent prostate-specific antigen screenings may lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men.Conducting frequent prostate-specific antigen (PSA) screenings was found to lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men, according to study data to be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.Read the full article here.
